NOVONIX Limited (ASX:NVX) (FRA:GC3) (OTCMKTS:NVNXF) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries. NOVONIX's mission is to support the global deployment of lithium-ion battery technologies for a cleaner energy future.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to announce that it has completed a $5.5 million Convertible Loan Note issue to institutional and Sophisticated Investors to provide additional working capital as the PUREgraphite business transitions into production, sales and to an expected positive cash flow position in CY19.
NOVONIX Ltd (ASX:NVX) provides the Company's latest presentation.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to announce that it has agreed to sponsor the Professor Mark Obrovac Battery Research Group at Dalhousie University.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to announce conditional funding of $487,693 CDN from the Natural Research Council of Canada Industrial Research Assistance Program.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to announce that its 100%-owned battery cell pilot manufacturing line is now fully commissioned and operational, producing cylindrical cells and pouch cells.
ASX-listed NOVONIX Limited (ASX:NVX) hereby provides an update relating to the trade sanctions between the USA and China regarding graphite imports to the USA.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to confirm the commencement of Mr Andrew N. Liveris AO on its Board of Directors today.
NOVONIX Ltd (ASX:NVX) provides the Company's latest presentation.
Further to the announcement on 15 May 2018 regarding DOE funding granted to NOVONIX's (ASX:NVX) business partner, the following updated announcement is released for clarification purposes to correct the DOE reference numbers for each grant and the timing of the issue of those grants.
ASX-listed NOVONIX Limited (ASX:NVX) is pleased to formally announce the effective date for the appointment of Andrew N. Liveris AO to its Board of Directors as 1 July 2018.
